Longbow Finance’s AbbVie ABBV Stock Holding History

Longbow Finance’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.99M	Sell	45,918 -15,209	-25%	-$3.37M	1.81%	14
2025 Q4	$14M	Sell	61,127 -37,716	-38%	-$8.59M	2.36%	9
2025 Q3	$22.9M	Hold	98,843	–	–	2.26%	10
2025 Q2	$18.3M	Buy	98,843 +37,626	+61%	+$6.99M	1.96%	12
2025 Q1	$12.8M	Buy	61,217 +21,952	+56%	+$4.27M	1.54%	17
2024 Q4	$6.98M	Buy	39,265 +1,860	+5%	+$342K	0.76%	44
2024 Q3	$7.39M	Buy	37,405 +8,641	+30%	+$1.61M	0.79%	33
2024 Q2	$4.93M	Sell	28,764 -1,544	-5%	-$256K	0.51%	46
2024 Q1	$5.52M	Buy	+30,308	New	+$5.22M	0.56%	48

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Longbow Finance's ABBV Position: Q1 2026 in Review

Longbow Finance reduced its AbbVie (ABBV) stake by 25% in Q1 2026, selling an estimated $3.37M and leaving 45,918 shares worth $9.99M. The position accounts for 1.81% of the portfolio, ranked #14.

Longbow Finance first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. The position peaked at $22.9M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Longbow Finance held 45,918 shares of AbbVie worth $9.99M as of Q1 2026.
Longbow Finance sold 15,209 AbbVie shares in Q1 2026, an estimated $3.37M.
AbbVie made up 1.81% of Longbow Finance's portfolio in Q1 2026, its #14 holding.
Longbow Finance first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
Longbow Finance's AbbVie position peaked at $22.9M in Q3 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Longbow Finance's 13F filing for Q1 2026, filed 12 May 2026.